XML 12 R48.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Commitments and Contingencies (Details Textual) (USD $) | 6 Months Ended | 12 Months Ended | 6 Months Ended | 0 Months Ended | 1 Months Ended | 6 Months Ended | 0 Months Ended | 6 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 30, 2014 | Dec. 31, 2013 | Jun. 30, 2014 Medeor [Member] | Dec. 31, 2007 Licensing Agreements [Member] Drugs | May 31, 2014 Licensing Agreements [Member] | Jun. 30, 2014 Licensing Agreements [Member] | Dec. 31, 2007 Licensing Agreements [Member] Minimum [Member] | Dec. 31, 2007 Licensing Agreements [Member] Maximum [Member] | Jun. 30, 2014 Lease Agreements [Member] | Dec. 31, 2013 Lease Agreements [Member] | Dec. 31, 2012 Lease Agreements [Member] | Jun. 30, 2014 Legal [Member]
Operating Leased Assets [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Questionable expense |  |  |  | $ 1,500,000 |  |  |  |  |  |  |  |
Number of licensed products |  |  |  | 2 |  |  |  |  |  |  |  |
Common stock shares exchange |  |  |  |  |  |  | 15 years | 20 years |  |  |  |
Royalties description |  |  |  |  |  |  |  |  | 67,800 | 64,600 | 13,300 |
Questionable expense |  |  |  |  |  |  |  |  |  |  |  | 1,500,000
Common stock shares exchange |  |  |  |  |  |  |  |  |  |  |  | 868,213
Royalties description | License fee of $1,500,000 and will earn royalties of up to 12% of net sales for up to two licensed products it is currently developing. |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock to acquire Medeor, License agreement |  | $ 3,750,000 |  |  |  |  |  |  |  |  |  |
Royalty payments description |  |  | (A) royalty payments up to 2% on net sales of licensed products that are not sold by sublicensee and (B) on each and every sublicense earned royalty payment received by licensee from its sublicensee on sales of license product. |  |  |  |  |  |  |  |  |
Royalty received by licensee description |  |  | (i) 20% of the royalties received by licensee; or (ii) up to 2% of net sales of sublicensee. The Company will also make milestone payments of up to $4 million and up to $2 million, for the first commercial sale of product in the field that has a single active pharmaceutical ingredient, and for the first commercial sale of product in the field of product that has more than one active pharmaceutical ingredient, respectively. |  |  |  |  |  |  |  |  |

X
- Definition Common stock shares exchange. + References No definition available. + Details
Name: | relm_CommonStockSharesExchange
Namespace Prefix: | relm_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Doubtful expense. + References No definition available. + Details
Name: | relm_DoubtfulExpense
Namespace Prefix: | relm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition License expiry term. + References No definition available. + Details
Name: | relm_LicenseExpiryTerm
Namespace Prefix: | relm_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of licensed products. + References No definition available. + Details
Name: | relm_NumberOfLicensedProducts
Namespace Prefix: | relm_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties description. + References No definition available. + Details
Name: | relm_RoyaltiesDescription
Namespace Prefix: | relm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of Royalty Payments. + References No definition available. + Details
Name: | relm_RoyaltyPaymentsDescription
Namespace Prefix: | relm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty Received by Licensee Description. + References No definition available. + Details
Name: | relm_RoyaltyReceivedByLicenseeDescription
Namespace Prefix: | relm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References No definition available. + Details
Name: | us-gaap_LeaseAndRentalExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_OperatingLeasedAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Value of stock issued pursuant to acquisitions during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueAcquisitions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration